Schroder Capital

Schroder Capital is the private assets investment arm of Schroders, a prominent global asset management firm. The division manages a diverse range of investment strategies, including a specialized focus on the healthcare and life sciences sectors through private equity and venture capital. In 2024, the firm significantly enhanced its biotechnology investment capabilities by acquiring Arix Bioscience, a venture capital firm dedicated to breakthrough life science companies. Schroder Capital invests in innovative businesses across various stages, from early-stage venture capital to late-stage growth and buyouts. Their healthcare investment portfolio spans therapeutics, medical technology, and healthcare services, aiming to support medical innovation that addresses significant unmet needs. The firm operates a global platform, leveraging extensive expertise to provide strategic support and capital to its portfolio companies.